This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
autonomous-vehicles: Archive
How Investors Can Grab Better Returns for Construction Using the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
MTZPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-esp earnings-expectations earnings-outlook fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
How Investors Can Grab Better Returns for Computer and Technology Using the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
CMBMPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-esp earnings-expectations earnings-outlook fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Northfield (NFBK) Is a Great Choice for "Trend" Investors, Here's Why
by Zacks Equity Research
Northfield (NFBK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
NFBKPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-performance ride-hailing saas self-driving-cars smart-health social-media stock-price-change stock-price-movement vaccines
Here Is Why Bargain Hunters Would Love Fast-paced Mover Penske (PAG)
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Penske (PAG) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
PAGPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Fast-paced Momentum Stock Avis Budget (CAR) Is Still Trading at a Bargain
by Zacks Equity Research
Avis Budget (CAR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
CARPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
If You Invested $1000 in Alphabet 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
GOOGLNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing growth-investors growth-stocks high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media
If You Invested $1000 in Crocs 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
CROXNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing growth-investors growth-stocks high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media
If You Invested $1000 in Tesla a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
TSLAPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing growth-investors growth-stocks high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media
If You Invested $1000 in KB Home a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
KBHNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing growth-investors growth-stocks high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media
Is Vanguard International Growth Investor (VWIGX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VWIGX
VWIGXPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing equity fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Is JPMorgan Small Cap Growth Fund A (PGSGX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PGSGX
PGSGXNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing equity fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Is Oppenheimer Global Opportunities A (OPGIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for OPGIX
OPGIXNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing equity fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Is PRIMECAP Odyssey Growth Fund (POGRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for POGRX
POGRXPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing equity fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Is PONAX a Strong Bond Fund Right Now?
by Zacks Equity Research
MF Bond Report for PONAX
PONAXNegative Net Change
ad-tech automation autonomous-vehicles batteries bond cell-therapy creator-economy dna-sequencing energy fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Should SPDR Portfolio S&P 500 Value ETF (SPYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYV
SPYVPositive Net Change JPMPositive Net Change BRK.BPositive Net Change DISNegative Net Change VTVPositive Net Change IWDPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dividend dna-sequencing etf expenses fin-tech furniture-retailers gambling gene-editing gene-therapy holdings home-buying-apps immuno-therapy index market-capitalization medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?
by Zacks Equity Research
Sector ETF report for SBIO
SBIOPositive Net Change XLVPositive Net Change VHTPositive Net Change
ad-tech apparel automation autonomous-vehicles batteries cell-therapy creator-economy dividend dna-sequencing etf expenses fin-tech furniture-retailers gene-editing gene-therapy hmo holdings home-buying-apps hospitals immuno-therapy index medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media us-equities vaccines
Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QUS
QUSPositive Net Change AAPLPositive Net Change MSFTNegative Net Change JNJNegative Net Change SPYPositive Net Change IVVPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dividend dna-sequencing etf expenses fin-tech furniture-retailers gene-editing gene-therapy holdings home-buying-apps immuno-therapy index medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HBANPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked undervalued-stocks vaccines value-stocks
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
NOWNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing growth-investors growth-stocks high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
STLDNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why Ralph Lauren (RL) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
RLPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
LDOSPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Integra LifeSciences (IART) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IARTPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
After Golden Cross, Repligen (RGEN)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RGENNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy daily-movers dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna moving-average-crossover oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Why This 1 Retail and Wholesale Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
WMTNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-estimates fin-tech furniture-retailers gene-editing gene-therapy growth-investing home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-consensus-estimate zacks-rank